Tilray Extraction EU

Cantanhede, PortugalFounded 2017

Share:X / Twitter LinkedIn Suggest a correction

About Tilray Extraction EU

Tilray's European extraction facility in Portugal produces EU-GMP certified cannabis extracts and oils for distribution across European medical cannabis markets.

Key Facts

1Operates an EU-GMP certified cannabis cultivation and extraction facility in Cantanhede, Portugal
2Supplies medical cannabis extracts to pharmacies across Germany, Italy, and other European markets

Latest News

Cannabis Stocks Rally as DEA Moves Marijuana to Schedule III

4d ago

AKAN surges alongside TLRY and CGC as federal rescheduling triggers sector-wide momentum with June 2026 hearing set to finalize broader cannabis reclassification.

Major Cannabis Stocks Plunge on Rescheduling Reality Check

5d ago

TLRY, CGC, ACB, CRON, and OGI tumble as investors reassess limited impact of federal cannabis reclassification on Canadian operators and market fundamentals.

Cannabis Stocks Plunge as Rescheduling Optimism Fades

5d ago

Major cannabis operators including TLRY, CGC, and ACB tumble as investors reassess limited impact from federal reclassification prospects.

TLRY Stock Plunges 19% as Cannabis Sector Faces Mounting Pressure

5d ago

Tilray Brands shares tumble amid broader cannabis market selloff, raising questions about sector fundamentals and investor appetite for marijuana stocks.

Cannabis Stocks Whipsaw on Federal Rescheduling Uncertainty

5d ago

TLRY and cannabis equities experience volatile trading as investors parse mixed signals on federal marijuana policy changes and regulatory timeline.

View all TLRY news

Frequently Asked Questions

Why did Tilray choose Portugal for European extraction?

Portugal offers favorable climate for cannabis cultivation, competitive operating costs, and EU membership enabling export of GMP-certified products across European medical markets.

What EU markets does Tilray supply?

Tilray's Portuguese facility supplies medical cannabis extracts primarily to Germany, the largest European medical cannabis market, as well as Italy, Poland, and other EU countries.